Adherence of synovial cells on EDA-containing fibronectin

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1685-1692

  Hino, Kazuo ^a   Maeda, Toshinaga ^b   Sekiguchi, Kiyotoshi ^b   Shiozawa, Kazuko ^c   Hirano, Hisanobu ^d   Sakashita, Eiji ^d   Shiozawa, Shunichi ^a  

^a KOBE UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c Department of Surgery   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EDOXUDINE; FIBRONECTIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MIGRATION; CELL TRANSFORMATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; SYNOVIAL FLUID; SYNOVIOCYTE; WOUND HEALING;

EID: 0029782997     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391011     Document Type: Article

References (34)

1. Hynes RO: Fibronectins. New York, Springer-Verlag, 1990
2. Hynes RO, Yamada KM: Fibronectins: multifunctional modular glycoproteins. J Cell Biol 95:369-377, 1982
3. Hynes RO: Molecular biology of fibronectin. Annu Rev Cell Biol 1:67-90, 1985
4. French-Constant C: Alternative splicing of fibronectin: many different proteins but few different functions. Exp Cell Res 221:261-271, 1995
5. French-Constant C, Hynes RO: Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 106:375-388, 1989
6. Oyama F, Hirohashi S, Shimosato Y, Titani K, Sekiguchi K: Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J Biol Chem 264:10331-10334, 1989
7. French-Constant C, van de Water L, Dvorak HF, Hynes RO: Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914, 1989
8. Peters JH, Maunder RJ, Woolf AD, Cochrane CG, Ginsberg MH: Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med 113:586-597, 1989
9. Ylètupa S, Haglund C, Mertaniemi P, Vahtera E, Partanen P: Cellular fibronectin in serum and plasma: a potential new tumor marker? Br J Cancer 71:578-582, 1995
10. Umemoto R, Asakura S, Kariya Y, Yonekawa M, Kawamura A, Komai T, Sekiguchi K, Hirano H, Hino K, Sakashita E, Matsuda M: Cellular fibronectin in plasma: its implications in fibrinogen-associated cryoprecipitation and other related reactions. Blood Coagul Fibrinolysis 4:127-131, 1993
11. Walle TK, Vartio T, Helve T, Virtanen I, Kurki P: Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration. Scand J Immunol 31:535-540, 1990
12. Cutolo M, Picasso M, Ponassi M, Sun MZ, Balza E: Tenascin and fibronectin distribution in human normal and pathological synovium. J Rheumatol 19:1439-1447, 1992
13. Hino K, Shiozawa S, Kuroki Y, Ishikawa H, Shiozawa K, Sekighchi K, Hirano H, Sakashita E, Miyashita K, Chihara K: EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 38:678-683, 1995
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
15. Hirano H, Tachikawa T, Hino K, Sakashita E, Sekiguchi K: Development of enzyme-linked immunosorbent assay (ELISA) for the detection of cellular type fibronectin by EDA-region specific monoclonal antibody. J Clin Lab Instruments Reagents (in Japanese) 15:179-184, 1992
16. Laine RA, Fisher SJ, Zhu BCR: Preparation of placental (fetal tissue) fibronectin and its carbohydrates. Methods Enzymol 144: 420-429, 1987
17. Mosesson MW, Unfleet RA: The cold insoluble globulin of human plasma part 1 purification primary characterization and relationship to fibrinogen and other cold insoluble components. J Biol Chem 245:5728-5736, 1970
18. Kornblihtt AR, Vibe-Pedersen K, Baralle FE : Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res 12:5853-5868, 1984
19. Sekiguchi K, Siri A, Zardi L, Hakomori S: Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. J Biol Chem 260:5105-5114, 1985
20. Borsi L, Castellani P, Balza E, Siri A, Pellecchia C, Scalzi FD, Zardi L: Large-scale procedure for the purification of fibronectin domains. Anal Biochem 155:335-345, 1986
21. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
22. Shiozawa S, Yosihara R, Kuroki Y, Fujita T, Shiozawa K, Imura S: Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann Rheum Dis 51:869-873, 1992
23. Burton-Wurster N, Lust G: Molecular and immunologic differences in canine fibronectins from articular cartilage and plasma. Arch Biochem Biophys 269:32-45, 1989
24. Shiozawa K, Shiozawa S, Shimizu S, Fujita T: Fibronectin on the surface of articular cartilage in rheumatoid arthritis. Arthritis Rheum 27:615-622, 1984
25. Dalton BA, McFarland CD, Underwood PA, Steele JG: Role of heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J Cell Sci 108:2083-2092, 1995
26. McCarthy JB, Chelberg MK, Mickelson DJ, Furcht LT: Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry 27:1380-1388, 1988
27. Langris M, Daireaux M, Jouis V, Bocquet J, Loyau G: Interleukin-1-like factor (mononuclear cell factor) modulates proteoglycan synthesis in cultured human synovial cells. Biochim Biophys Acta 927:34-42, 1987
28. Noble DP, Lewthwaite JC, Dudhia J, Blake S, Henderson B, Hardingham TE: In situ hybridisation for decorin mRNA in rabbit synovium during antigen-induced arthritis. Agents Actions Suppl 39:249-253, 1993
29. Dodge GR, Boesler EW, Jimenez SA: Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells. Lab Invest 73:649-657, 1995
30. Drake SL, Klein DJ, Mickelson DJ, Oegema TR, Furcht LT, McCarthy JB: Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide. J Cell Biol 117:1331-1341, 1992
31. Woods A, McCarthy JB, Furcht LT, Couchman JR: A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell 4:605-613, 1993
32. Woods A, Couchman JR: Heparan sulfate proteoglycans and signalling in cell adhesion. Adv Exp Med Biol 313:87-96, 1992
33. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K: Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J Cell Sci 106:55-65, 1993
34. Lehto VP, Virtanen I: Formation of stress fibers and focal adhesion sites in monensin-exposed cultured human fibroblasts in response to exogenously added cellular fibronectin. Exp Cell Res 158:563-569, 1985